globalbarry. Company Intelligence Engine

NYMOX PHARMACEUTICAL CORP

NYMXF CIK 0001018735 · In Vitro & In Vivo Diagnostic Substances (SIC 2835)

Disclosed SEC business address
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, A8, H4M 2V2

NYMOX PHARMACEUTICAL CORP (ticker NYMXF, CIK 0001018735) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: In Vitro & In Vivo Diagnostic Substances (SIC 2835). Disclosed business address country: Quebec, Canada. Every item is grounded on the cited public source — no figures are fabricated.

Top findings public preview

  • FACT Disclosed industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
  • FACT Country of disclosed business address: Quebec, Canada
  • FACT 20-F/A filed (period 2025-12-31) 2026-09-29 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 0 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.